Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function

Transplantation

Volumn 62, Issue 11, 1996, Pages 1634-1642

  Benediktsson, Hallgrimur ^a,d   Chea, Rith ^a   Davidoff, Allen ^a   Paul, Leendert C ^b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROCHLOROTHIAZIDE; RESERPINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CAPILLARY PRESSURE; CONTROLLED STUDY; GLOMERULUS CAPILLARY; GRAFT REJECTION; HYPERTENSION; IMMUNOMODULATION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CYCLOSPORINE; GRAFT REJECTION; GRAFT SURVIVAL; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; PROTEOGLYCANS; PUNCTURES; RATS; RATS, INBRED F344; RATS, INBRED LEW;

EID: 0030448983     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199612150-00018     Document Type: Article

References (45)

1. Schweitzer EJ, Matas AJ, Gillingham KJ, et al. Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg 1991; 214: 679.
2. Paul LC. Chronic renal transplant loss [Review]. Kidney Int 1995; 47: 1491.
3. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection [Review]. Transplantation 1995; 59: 313.
4. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162.
5. Terasaki PI, Koyama H, Cecka JM, Gjertson DW. The hyperfiltration hypothesis in human renal transplantation. Transplantation 1994; 27: 1450.
6. Feldman HI, Fazio I, Roth D, et al. Recipient body size and cadaveric renal allograft survival. J Am Soc Nephrol 1996; 17: 151.
7. Dimeny E, Wahlberg J, Lithell H, Fellström B. Hyperlipidemia in renal transplantation. Risk factor for long-term graft outcome. Eur J Clin Invest 1995; 25: 574.
8. Modena FM, Hostetter TH, Salahudeen AK, et al. Progression of kidney disease in chronic renal transplant rejection. Transplantation 1991; 52: 239.
9. Brazy PC, Pirsch JD, Belzer FO. Factors affecting renal allograft function in long-term recipients. Am J Kidney Dis 1992; 19: 558.
10. Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85.
11. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? [Editorial]. Kidney Int 1990; 38: 384.
12. Yoshida Y, Fogo A, Ichikawa I. Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 1989; 35: 654.
13. Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985; 76: 667.
14. Keane WF, Kasiske BL, O'Donnell MP. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis [Review]. Am J Nephrol 1988; 8: 261.
15. Mackenzie HS, Tullius SG, Heemann UW, et al. Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest 1994; 94: 2148.
16. Kingma I, Chea R, Davidoff AW, et al. Glomerular capillary pressures in long-surviving rat renal allografts. Transplantation 1993; 56: 53.
17. de Heer E, Davidoff AW, van der Wal A, van Geest M, Paul LC. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab Invest 1994; 70: 494.
18. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993.
19. Paul LC, Davidoff A, Benediktsson H. Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor. Transplantation 1994; 57: 1767.
20. Siegl PK, Chang RS, Mantlo NB, et al. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. J Pharmacol Exp Ther 1992; 262: 139.
21. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
22. van den Born J, van den Heuvel LP, Bakker MA, et al. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int 1993; 43: 454.
23. van den Born J, van den Heuvel LP, Bakker MA, et al. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 1992; 41: 115.
24. Dekan G, Gabel C, Farquhar MG. Sulfate contributes to the negative charge of podocalyxin, the major sialoglycoprotein of the glomerular filtration slits. Proc Natl Acad Sci USA 1991; 88: 5398.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248.
26. Andreucci VE. Measurement of hydrostatic pressure in superficial tubules and capillaries. In: Manual of renal micropuncture. Andreucci VE, ed. Naples: Idelson, 1978: 166.
27. Baylis C, Deen WM, Myers BD, Brenner BM. Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol 1976; 230: 1148.
28. Junaid A, Kren SM, Rosenberg ME, et al. Physiological and structural responses to chronic experimental renal allograft injury. Am J Physiol 1994; 267: F1102.
29. Sigmon DH, Carretero OA, Beierwaltes WH. Plasma renin activity and the renal response to nitric oxide synthesis inhibition. J Am Soc Nephrol 1992; 3: 1288.
30. Walker LA, Buscemi-Bergin M, Gellai M. Renal hemodynamics in conscious rats: effects of anesthesia, surgery, and recovery. Am J Physiol 1983; 245: F67.
31. Oliver JD, 3rd, Simons JL, Troy JL, et al. Proteinuria and impaired glomerular permselectivity in uninephrectomized fawn-hooded rats. Am J Physiol 1994; 267: F917.
32. Anderson S, Rennke HG, Brenner BM. Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int 1992; 41: 891.
33. Gaber L, Walton C, Brown S, Bakris G. Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs. Kidney Int 1994; 46: 161.
34. Garcia DL, Rennke HG, Brenner BM, Anderson S. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation. J Clin Invest 1987; 80: 867.
35. Odum J, Purkiss J, Naish PF. Influence of differing classes of antihypertensive agents on mesangial kinetics following partial renal ablation in rats. Nephrol Dial Transplant 1994; 9: 131.
36. Cheigh JS, Haschemeyer RH, Wang JC, et al. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertension 1989; 2: 341.
37. Bell L, Madri JA. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 1990; 137: 7.
38. Linz W, Wiemer G, Scholkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril [Review]. J Cardiovasc Pharmacol 1993; 22 (suppl 9): S1.
39. Ishidoya S, Morrissey J, McCracken R, et al. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995; 47: 1285.
40. Paul LC, Manting EH, Muzaffar SA. Glomerular mesangial cells and their extra-cellular matrix proteins in chronic rejection [Abstract]. In: Proceedings of the 14th American Society of Transplant Physicians Meeting. American Society of Transplant Physicians: 1995.
41. Bagchus WM, Jeunink MF, Elema JD. The mesangium in anti-Thy-1 nephritis. Influx of macrophages, mesangial cell hypercellularity, and macromolecular accumulation. Am J Pathol 1990; 137: 215.
42. Kiyama S, Nanishi F, Tomooka S, et al. Inhibitory effects of antihypertensive drugs on mesangial cell proliferation after anti-thymocyte serum (ATS)-induced mesangiolysis in spontaneously hypertensive rats [published erratum appears in Life Sci 1994; 55(24): 1973]. Life Sci 1994; 54: 1891.
43. Kingma I, Harmsen E, ter Keurs HE, et al. Cyclosporine-associated reduction in systolic myocardial function in the rat. Int J Cardiol 1991; 31: 15.
44. Banijamali HS, ter Keurs MHC, Paul LC, ter Keurs HEDJ. Excitation contraction coupling in rat heart: influence of cyclosporine A. Cardiovascular Res 1993; 27: 1845.
45. Elzinga LW, Rosen S, Bennett WM. Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake. J Am Soc Nephrol 1993; 4: 214.